How many insider declarations has venBio Global Strategic Fund IV, L.P. filed?

venBio Global Strategic Fund IV, L.P. has filed 4 public insider declarations with SEC (Form 4).

What is venBio Global Strategic Fund IV, L.P.'s role?

venBio Global Strategic Fund IV, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does venBio Global Strategic Fund IV, L.P. report trades for?

venBio Global Strategic Fund IV, L.P. reports trades for Attovia Therapeutics, Inc..

What is venBio Global Strategic Fund IV, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 5.6M€ and disposals 0.

← Executives ★ Sign in to follow

VG

venBio Global Strategic Fund IV, L.P.

·SEC (Form 4)

Attovia Therapeutics, Inc.

0

Total declarations

0

Company

€6m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the complete record of transactions filed by venBio Global Strategic Fund IV, L.P.. Officer active across 1 company, notably Attovia Therapeutics, Inc.. In total, 4 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €5.6m. History available since 6 August 2026. The latest transaction was disclosed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to venBio Global Strategic Fund IV, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Attovia Therapeutics, Inc. (US)

Declarations4 total

●

venBio Global Strategic Fund IV, L.P.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

0SEC ↗

2,311,870 sharesCommon StockSEC:0000905148-26-003548:0

●

venBio Global Strategic Fund IV, L.P.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

0SEC ↗

821,998 sharesCommon StockSEC:0000905148-26-003548:1

●

venBio Global Strategic Fund IV, L.P.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

0SEC ↗

665,147 sharesCommon StockSEC:0000905148-26-003548:2

▲

venBio Global Strategic Fund IV, L.P.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

$6M0SEC ↗

382,352 shares@ US$17.00Common StockSEC:0000905148-26-003548:3

Canonical exit: 4 Nov 2026 (T+90)

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

VG

venBio Global Strategic Fund IV, L.P.

·SEC (Form 4)

Attovia Therapeutics, Inc.

0

Total declarations

0

Company

€6m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the complete record of transactions filed by venBio Global Strategic Fund IV, L.P.. Officer active across 1 company, notably Attovia Therapeutics, Inc.. In total, 4 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €5.6m. History available since 6 August 2026. The latest transaction was disclosed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.